uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Oxlumo
Authorised
Human
Orphan medicine
Details
EMA number
EMEA/H/C/005040
ATC code
A16AX18
Authorisation
19 November 2020
Revision
6
EMA page
Therapeutic indication
Treatment of primary hyperoxaluria type 1 (PH1) in all age groups.
MeSH:
Hyperoxaluria, Primary
Group:
Other alimentary tract and metabolism products
Active substances
Lumasiran sodium
Marketing Authorisation Holder
Alnylam Netherlands B.V.
MAH
Timeline
Filter by authority:
EMA
Oxlumo authorised
19 Nov 2020
authorised
regulatory
Oxlumo | uMedical